Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 198, Issue -, Pages -Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2023.110599
Keywords
Glycemic control; Type 2 diabetes; Age; Diabetic medication
Categories
Ask authors/readers for more resources
This study aimed to assess the impact of age group on glycemic control and diabetes treatment in Japanese patients with type 2 diabetes. The study analyzed data from approximately 40,000 patients/year from 2012 to 2019 using cross-sectional and retrospective analyses. The results showed minimal changes in glycemic control across all age groups during the study period. Younger patients, especially those treated with insulin, had higher glycated hemoglobin A1c (HbA1c) values compared to older patients. Different age groups showed variations in prescribed medications, with the increasing use of sodium glucose transporter 2 inhibitors observed, particularly in younger patients.
Aims: This study aimed to evaluate changes in glycemic control and diabetes treatment by age group in Japanese patients with type 2 diabetes. Methods: The study included the results of approximately 40,000 patients/year using cross-sectional and retrospective analyses from 2012 to 2019. Results: There was little change in the glycemic control status in all age groups during the study period. However, by age group, patients aged <= 44 years continued to have the highest glycated hemoglobinA1c (HbA1c) values during the study period (7.4 % +/- 1.7 % in 2012 and 7.4 % +/- 1.5 % in 2019), especially in insulin-treated patients (8.3 % +/- 1.9 % in 2012 and 8.4 % +/- 1.8 % in 2019). Biguanides and dipeptidyl peptidase-4 inhibitors were widely prescribed. Sulfonylurea and insulin use showed a decreasing trend, but older patients had a higher percentage of prescriptions. Sodium glucose transporter 2 inhibitors were prescribed rapidly, especially in younger patients. Conclusions: There were no obvious changes in glycemic control over time in the study period. The mean HbA1c level was higher in younger patients, which suggested that improvement is required. In older patients, there was a trend toward greater emphasis on management to avoid hypoglycemia. Different treatment strategies based on age showed different drug choices.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available